ATE386748T1 - Verwendung von liganden von cd52 antigen zur behandlung von soliden tumoren und von knochenkrebserkrankungen - Google Patents
Verwendung von liganden von cd52 antigen zur behandlung von soliden tumoren und von knochenkrebserkrankungenInfo
- Publication number
- ATE386748T1 ATE386748T1 AT03029464T AT03029464T ATE386748T1 AT E386748 T1 ATE386748 T1 AT E386748T1 AT 03029464 T AT03029464 T AT 03029464T AT 03029464 T AT03029464 T AT 03029464T AT E386748 T1 ATE386748 T1 AT E386748T1
- Authority
- AT
- Austria
- Prior art keywords
- solid tumors
- bone cancer
- cancer diseases
- treat solid
- antigen ligands
- Prior art date
Links
- 102000013135 CD52 Antigen Human genes 0.000 title abstract 3
- 108010065524 CD52 Antigen Proteins 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 title abstract 2
- 206010005949 Bone cancer Diseases 0.000 title 1
- 208000018084 Bone neoplasm Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2893—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03029464A EP1544213B1 (de) | 2003-12-19 | 2003-12-19 | Verwendung von Liganden von CD52 Antigen zur Behandlung von soliden Tumoren und von Knochenkrebserkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE386748T1 true ATE386748T1 (de) | 2008-03-15 |
Family
ID=34486276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03029464T ATE386748T1 (de) | 2003-12-19 | 2003-12-19 | Verwendung von liganden von cd52 antigen zur behandlung von soliden tumoren und von knochenkrebserkrankungen |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20070148191A1 (de) |
| EP (1) | EP1544213B1 (de) |
| AT (1) | ATE386748T1 (de) |
| DE (1) | DE60319240D1 (de) |
| WO (1) | WO2005058966A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110212086A1 (en) * | 2006-01-19 | 2011-09-01 | Genzyme Corporation | GITR Antibodies For The Treatment of Cancer |
| WO2010002862A2 (en) * | 2008-07-01 | 2010-01-07 | Aveo Pharmaceuticals, Inc. | Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
| WO2010027370A1 (en) * | 2008-09-08 | 2010-03-11 | The Regents Of The University Of Michigan | Compositions and methods for the treatment of solid tumor cancers |
| EP2419113B1 (de) * | 2009-04-13 | 2017-05-10 | Apceth GmbH & Co. KG | Technisch hergestellte mesenchym-stammzellen und verfahren zu ihrer verwendung bei der behandlung von tumoren |
| US11505611B2 (en) | 2020-08-21 | 2022-11-22 | Genzyme Corporation | FGFR3 antibodies and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7678391B2 (en) * | 2000-04-26 | 2010-03-16 | Queen's University At Kingston | Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
| US7105682B2 (en) * | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
| AU2002360525A1 (en) * | 2001-12-06 | 2003-06-23 | University Of Florida | Targeting leukemia cells |
| KR20030076448A (ko) * | 2002-03-21 | 2003-09-26 | 주식회사 코메드 | 항-ｒａｎｋ 단클론 항체 및 이를 함유한 약학 조성물 |
| EP1530474A1 (de) * | 2002-07-19 | 2005-05-18 | Ludwig Institute For Cancer Research | Erhöhung der wirkung von radioimmuntherapie in der behandlung von tumoren |
| AU2003303521A1 (en) * | 2002-12-31 | 2004-07-29 | Genta Incorporated | Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia |
-
2003
- 2003-12-19 EP EP03029464A patent/EP1544213B1/de not_active Expired - Lifetime
- 2003-12-19 AT AT03029464T patent/ATE386748T1/de not_active IP Right Cessation
- 2003-12-19 DE DE60319240T patent/DE60319240D1/de not_active Expired - Lifetime
-
2004
- 2004-10-08 US US10/582,697 patent/US20070148191A1/en not_active Abandoned
- 2004-10-08 WO PCT/EP2004/011302 patent/WO2005058966A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1544213B1 (de) | 2008-02-20 |
| EP1544213A1 (de) | 2005-06-22 |
| US20070148191A1 (en) | 2007-06-28 |
| DE60319240D1 (de) | 2008-04-03 |
| WO2005058966A2 (en) | 2005-06-30 |
| WO2005058966A3 (en) | 2005-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE453653T1 (de) | Platinkomplexe zur behandlung von tumoren | |
| ATE516818T1 (de) | Auristatin-konjugate und ihre verwendung zur behandlung von krebs, einer autoimmunkranheit oder einer infektionskrankheit | |
| ATE345130T1 (de) | Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen | |
| ATE493979T1 (de) | Zusammensetzungen und verfahren zur behandlung primärer und metastatischer erkrankungen mithilfe arsentrioxid | |
| ATE468331T1 (de) | Neue cyanopyridine-derivate zur behandlung von krebs und anderer erkrankungen | |
| ATE410446T1 (de) | Zusammensetzungen zur behandlung und diagnose von eierstockkrebs | |
| ATE414512T1 (de) | Kombinationstherapie zur behandlung von krebs | |
| DE60330889D1 (de) | Botulinum toxin zur behandlung von magengeschwür und gastroösophagealen reflux | |
| ATE422358T1 (de) | Kombinationstherapie mittels reovirus und anti- antireovirus antikörpern zur behandlung von ras- vermittelten, proliferativen erkrankungen | |
| DE60335293D1 (de) | Pyrrolopyridazin-verbindungen und verwendungsverfahren dafür zur behandlung von proliferativen erkrankungen | |
| MXPA05012723A (es) | Tratamiento con anticuerpos anti-vgf. | |
| DE60306505D1 (de) | Verfahren zur behandlung von brustdrüsenerkrankungen | |
| ATE443704T1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| WO2003087831A3 (en) | Proteins involved in breast cancer | |
| ATE531688T1 (de) | Verbindungen zur modulation des rage-rezeptors | |
| EP1694364A4 (de) | System zur behandlung und prävention von brustkrebs | |
| ATE421324T1 (de) | Verwendung von isochinolin-derivaten zur behandlung von krebs und erkrankungen im zusammenhang mit map kinase | |
| ATE386748T1 (de) | Verwendung von liganden von cd52 antigen zur behandlung von soliden tumoren und von knochenkrebserkrankungen | |
| DE602004021363D1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen | |
| ATE439130T1 (de) | Epothilonderivat zur behandlung von hepatoma und anderen krebserkrankungen | |
| DE60224429D1 (de) | Pharmazeutische zusammensetzung zur verwendung bei der behandlung von malignen erkrankungen, umfassend eine kombination aus bisphosphonaten, einem cox-2 inhibitor und einem taxol | |
| ATE384520T1 (de) | Kombinierte verwendung von einem fibrat und von orlistat zur behandlung von obesitas | |
| ATE329597T1 (de) | Die verwendung von einer 4- pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren | |
| DE60334289D1 (de) | Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen | |
| EP1663318A4 (de) | Radioisotop-chitosan-komplex zur behandlung von prostatakrebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |